Anonymous ID: 15e76d Sept. 2, 2024, 4:11 a.m. No.21520963   🗄️.is đź”—kun

>>21520930

Great Fire of London

en

https://en.wikipedia.orgwikiGreat_Fire_of_London

thumb

The Great Fire of London was a major conflagration that swept through central London from Sunday 2 September to Thursday 6 September 1666, gutting the medieval City of London inside the old Roman city wall, while also extending past the wall to the west. The death toll is generally thought to have been relatively small, although some historians have challenged this belief. The fire started in a bakery in Pudding Lane shortly after midnight on Sunday 2 September, and spread rapidly. The use of the major firefighting technique of the time, the creation of firebreaks by means of removing structures in the fire's path, was critically delayed due to the indecisiveness of the Lord Mayor, Sir Thomas Bloodworth. By the time large-scale demolitions were ordered on Sunday night, the wind had already fanned the bakery fire into a firestorm which defeated such measures. The fire pushed north on Monday into the heart of the City.

Anonymous ID: 15e76d Sept. 2, 2024, 5:22 a.m. No.21521212   🗄️.is đź”—kun   >>1221 >>1236 >>1256 >>1284

@lightworkerCoco

Hahaha  I didn’t know that this Pfizer CEO Albert Bourla got his medical degree as a veterinary? How a appropriate that #Horsepaste #ivermectin is the #cure for most if not all diseases from cancer to MS, to Lyme Disease to crones disease….. “They” weaponized parasites. “They” injected parasites in ticks, mosquitoes, flies, food, water air. “They” are sheer evil. #DirtRoadDiscussions #Hosea4 “My people are destroyed for lack of knowledge: because thou hast rejected knowledge”-Hosea 4:6

 



Dana17

@Dana17

Feb 1, 2023

And the vet did not suggest the “horse paste” #Ivermectin ?

#AlbertBourla #PfizerCEO #PfizerLiedPeopleDied finance.yahoo.com/news/pfizer-

 

finance.yahoo.com

Pfizer’s CEO, a former veterinarian, used a high-risk strategy to make vaccine history

 

Pfizer CEO Albert Bourla asked his team to "make the impossible possible," giving them 8 months to develop a safe COVID-19 vaccine. The result would make history.

 

Feb 02, 2023, 9:41 AM

 

 

Pfizer’s CEO, a former veterinarian, used a high-risk strategy to make vaccine history

 

Pfizer CEO Albert Bourla isn’t afraid of taking risks — and it’s paid off in big ways for the pharmaceutical and biotech giant.

 

When Bourla took over as Pfizer’s leader in 2019, he took a high-risk, high reward approach by betting heavily on cutting-edge science and the customer experience.

 

His strategy is paying off. After 16 years, Pfizer rejoined Fortune’s list of the Most Admired Companies, largely because of Bourla’s vision and the company’s historic COVID vaccine launch.

 

Bourla credits lessons from his parents surviving a Nazi occupation and his background in science as major drivers of his success.

 

His story is inspiring, with lessons that many can apply to their careers.

 

Background

Bourla was born to parents who survived the Nazi occupation of Thessalonika, Greece, the ancient city where he was born. His parents emphasized an important lesson: to live a positive life in the present, even if the past is dark.

 

His path to CEO was unconventional, but would be crucial to his success in the long term.

 

After graduating from the Veterinary School of Aristotle University of Thessaloniki where he studied veterinary medicine and received a Ph.D. in biotechnology of reproduction, he began his career as a vet.

 

In 1993, Bourla joined Pfizer as the technical director of the animal health division. He moved to New York in 2001 to serve as group marketing director for the US. Five years later, he became the area president of animal health for Europe, Africa, and the Middle East.

 

Finding a sweet spot with consumer health at Pfizer

In 2014, Bourla was promoted to head of the global vaccines, oncology, and consumer healthcare division.

 

He became group president of Pfizer Innovative Health in 2016 and served for a year, overseeing research and development in consumer healthcare, immunology, vaccines, and other sectors. During this time, he also created the Patient and Health Impact Group focused on making it easier for patients to use Pfizer’s platforms

 

Bourla continued to quickly rise up the ranks, and was promoted to chief operating officer in 2018. A year later, in 2019, he would be promoted to chief executive.

 

According to the Harvard Business Review, Bourla has focused on putting patients first in his two decades with Pfizer.

 

He emphasized the user experience, measuring success by the number of patients Pfizer served over sales numbers, and pushed the company to become more science-driven and innovative through a demanding leadership style that he attributes to his background in science and his Jewish heritage.

 

Smart decisions before COVID would pay off later

Shortly after he became CEO in 2019, Bourla restructured the company in a way that would prove beneficial when the COVID pandemic came months later.

 



 

https://finance.yahoo.com/news/pfizer-ceo-former-veterinarian-used-112200276.html